Nicobrand Limited
Registered name: NICOBRAND LIMITED
Part of Contraf -Nicotex-Tobacco Gmbh groupNicobrand Limited made £62.5m revenue and £19.9m profit in the year to 31 Dec 2025. read from filing text
Nicobrand Limited’s revenue fell 6% to £62.5m in the year to 31 Dec 2025, with £19.9m profit and 88 employees. The company is classified under “manufacture of pharmaceutical preparations” and is based in County Londonderry; we hold 4 years of its filed accounts.
- Status
- Active
- Location
- County Londonderry, Northern Ireland
- Age
- 28 yrs · since 1997
- Type
- Private Limited Company
Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently. From the filing: “The ultimate parent company is Contraf-Nicotex-Tobacco GmbH, a company registered at Herbststraße 8, 74072 Heilbronn, Germany.”
Key figures
Badges are automated estimates derived from the filed figures — not statements of fact about the company.
Financial history
| Year to | 31 Dec 2022 | 31 Dec 2023 | 31 Dec 2024 | 31 Dec 2025 |
|---|---|---|---|---|
| Disclosure | Full P&Lread from filing text | Full P&Lread from filing text | Full P&Lread from filing text | Full P&Lread from filing text |
| Profit & loss | ||||
| Revenue (turnover) | £16.1m | £28.7m | £66.3m | £62.5m |
| Cost of sales | £8.7m | £15.7m | £34.8m | £31.4m |
| Gross profit | £7.4m | £13m | £31.5m | £31.1m |
| Operating profit | £4.9m | £10.5m | £27.3m | £26.5m |
| Profit before tax | £4.9m | £10.5m | £27.3m | £26.5m |
| Profit after tax | £4m | £7.9m | £20.5m | £19.9m |
| Profit (best available) | £4m | £7.9m | £20.5m | £19.9m |
| Staff costs | £1.7m | £2.1m | £2.8m | £4.2m |
| Employees (average) | 40 | 49 | 65 | 88 |
| Ratios | ||||
| Profit margin | 24.9% | 27.6% | 30.9% | 31.8% |
| Gross margin | 45.9% | 45.3% | 47.5% | 49.7% |
| Revenue per employee | £403k | £585k | £1m | £710k |
| Profit per employee | £100k | £162k | £315k | £226k |
| Cash conversion | −32.1% | −59.4% | −42.3% | −99.8% |
| Growth (year on year) | ||||
| Revenue growth | — | ▲77.7% | ▲131.1% | ▼5.7% |
| Profit growth | — | ▲97.4% | ▲158.5% | ▼3.1% |
| Headcount growth | — | ▲22.5% | ▲32.6% | ▲35.4% |
| Balance sheet — indirect signals, not revenue | ||||
| Cash at bank | £2.1m | £2.9m | £2.5m | £11.1m |
| Net assets | £16.4m | £22.6m | £40.6m | £53m |
| Fixed assets | £5.3m | £6.5m | £47.7k | £9.2m |
| Current assets | £15m | £20m | £39.4m | £47.8m |
| Debtors | £5.4m | £9.3m | £25.4m | £14.4m |
| Deferred income | £4.4k | £3.9k | £3.4k | £19.6k |
| Cash from operations | −£1.6m | −£6.2m | −£11.6m | −£26.4m |
| Source | FullAccounts · bulk data May 2024 | FullAccounts · bulk data May 2024 | FullAccounts · bulk data Jul 2025 | FullAccounts · bulk data Sep 2026 |
How the business works
- Profit margin
- 31.8%
- Profit ÷ revenue.
- Gross margin
- 49.7%
- Gross profit ÷ revenue. High for software and services.
- Revenue per employee
- £710k
- Revenue ÷ average employees.
- Profit per employee
- £226k
- Profit ÷ average employees.
- Cash conversion
- −99.8%
- Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
- Fixed assets ÷ revenue
- 14.7%
- Capital intensity. Low = capital-light, cheaper to start.
- Deferred income ÷ revenue
- 0%
- Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
- Debtors ÷ revenue
- 23%
- Money owed by customers. Low = customers pay quickly.
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- ▲31%
- Now £53m
- Cash at bank
- ▲344%
- Now £11.1m
- Headcount
- ▲35%
- Now 88
- Deferred income
- ▲477%
- Now £19.6k
- Fixed assets
- ▲19136%
- Now £9.2m
Group structure
Ownership chain
- Contraf -Nicotex-Tobacco Gmbh (registered outside the UK register)ultimate parent75–100%
- Nicobrand Limitedthis company
Bands show the share of ownership each company holds in the one below it.
From the Persons with Significant Control register (corporate controllers only).
Similar profitable businesses
- Catalent CTS (Edinburgh) LimitedSwindon · Manufacture of pharmaceutical preparations
- Revenue
- £68.7m
- Profit
- £17.8m
- Staff
- 264
- Morningside Pharmaceuticals LimitedNorthampton · Manufacture of pharmaceutical preparations
- Revenue
- £75.3m
- Profit
- £13.4m
- Staff
- 47
- Neon Healthcare LtdHertford · Manufacture of pharmaceutical preparations
- Revenue
- £51.2m
- Profit
- £1.7m
- Staff
- 21
- Dermal Laboratories LimitedLoughton · Manufacture of pharmaceutical preparations
- Revenue
- £45.7m
- Profit
- £2.4m
- Staff
- 171
- Northumbria Pharma LtdSedgefield · Manufacture of pharmaceutical preparations
- Revenue
- £44.5m
- Profit
- £10.6k
- Staff
- 29
- Swedish Orphan Biovitrum LtdCambridge · Manufacture of pharmaceutical preparations
- Revenue
- £88.7m
- Profit
- £3.5m
- Staff
- 92
Sources
Latest figures from FullAccounts for the year to 31 Dec 2025 (profit £19.9m), from the Companies House accounts bulk data published Sep 2026. Spotted an error? Request a correction.
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.